Analysis of the pharmacokinetic interaction between cephalexin and quinapril by a nonlinear mixed-effect model

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 6, 1998, Pages 1463-1469

  Padoin, C ^a   Tod, M ^a   Perret, G ^a   Petitjean, O ^a  

^a AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFALEXIN; DRUG CARRIER; QUINAPRIL;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG COMPETITION; DRUG ELIMINATION; DRUG EXCRETION; DRUG TRANSPORT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031805190     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.6.1463     Document Type: Article

References (25)

1. Beal, S. L., A. Boeckman, and L. B. Sheiner. 1992. NONMEM user's guide, version IV. NONMEM Project Group, University of California, San Francisco.
2. Bins, J. W., and H. Mattie. 1988. Saturation of the tubular excretion of β-lactam antibiotics. Br. J. Clin. Pharmacol. 25:41-50.
3. Bowers, W. F., S. Fulton, and J. Thompson. 1984. Ultrafiltration versus equilibrium dialysis for determination of free fraction. Clin. Pharmacokinet. 9(Suppl. 1):49-60.
4. Couet, W., B. Reigner, J. P. Guedes, and T. Tozer. 1991. Theoretical model for both saturable rate and extent of absorption: simulation of cefatrizine data. J. Pharmacokinet. Biopharm. 19:271-285.
5. Dantzig, A., and L. Bergin. 1990. Uptake of cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2. Biochim. Biophys. Acta 1027:211-217.
6. Friedman, D. I., and G. L. Amidon. 1989. Intestinal absorption mechanism of dipeptide angiotensin converting enzyme inhibitors of the lysyl-proline type: lisinopril and SQ 29, 852. J. Pharm. Sci. 78:995-998.
7. Granero, L., M. J. Gimeno, F. Torres-Molina, J. Chesajimenez, and J. E. Peris. 1994. Studies on the renal excretion mechanisms of cefadroxil. Drug Metab. Dispos. 22:447-450.
8. Hori, R., K. Okumura, A. Kamiya, H. Nihira, and H. Nakano. 1983. Ampicillin and cephalexin in renal insufficiency. Clin. Pharmacol. Ther. 34:792-798.
9. Hu, M., and G. Amidon. 1988. Passive and carrier-mediated intestinal absorption components of captopril. J. Pharm. Sci. 77:1007-1011.
10. Jacolot, A., M. Tod, and O. Petitjean. 1996. Pharmacokinetic interaction between cefdinir and two angiotensin-converting enzyme inhibitors in rats. Antimicrob. Agents Chemother. 40:979-982.
11. Karlsson, M., and L. Sheiner. 1994. Estimation of bioavailability when clearance varies with time. Clin. Pharmacol. Ther. 55:623-637.
12. Kimura, T., T. Yamamoto, M. Mizuno, Y. Suga, S. Kitade, and H. Sezaki. 1983. Characterization of aminocephalosporin transport across rat small intestine. J. Pharmacobio-Dyn. 6:246-253.
13. Kramer, W., F. Girbig, U. Gutjahr, S. Kowalewski, F. Adam, and W. Schiebler. 1992. Intestinal absorption of β-lactam antibiotics and oligopeptides: functional and stereospecific reconstitution of the oligopeptide transport system from rabbit small intestine. Eur. J. Biochem. 204:923-930.
14. Lin, J., I. Chen, E. Ulm, and E. Duggan. 1988. Differential renal handling of angiotensin-converting enzyme inhibitors enalaprilat and lisinopril in rats. Drug. Metab. Dispos. 16:392-396.
15. Paintaud, G., G. Aluan, M. L. Dahl, A. Grahnen, J. Sjövall, and J. O. Svensson. 1992. Nonlinearity of amoxicillin absorption kinetics in human. Eur. J. Clin. Pharmacol. 43:283-288.
16. Reigner, B., W. Couet, J. P. Guedes, J. B. Fourtillan, and T. Tozer. 1990. Saturable rate of cefatrizine absorption after oral administration to humans. J. Pharmacokinet. Biopharm. 18:17-34.
17. Sheiner, L. B., and T. M. Ludden. 1992. Population pharmacokinetics/dynamics. Annu. Rev. Pharmacol. Toxicol. 32:185-209.
18. Sinko, P., and G. Amidon. 1989. Characterization of the oral absorption of β-lactam antibiotics. II. Competitive absorption and peptide carrier specificity. J. Pharm. Sci. 78:723-727.
19. Sjövall, J., G. Aluan, and D. Westerlund. 1985. Dose-dependent absorption of amoxycillin and bacampicillin. Clin. Pharmacol. Ther. 38:241-250.
20. Sugawara, M., T. Toda, K. Iseki, K. Miyazaki, H. Shiroto, Y. Kondo, and J. I. Uchino. 1992. Transport characteristics of cephalosporin antibiotics across intestinal brush-border membrane in man, rat and rabbit. J. Pharm. Pharmacol. 44:968-972.
21. Sugawara, M., T. Toda, M. Kobayashi, K. Iseki, K. Miyazaki, H. Shiroto, J. I. Uchino, and Y. Kondo. 1994. The inhibitory effects of cephalosporin and dipeptides on ceftibuten uptake by human and rat intestinal brush-border membrane vesicles. J. Pharm. Pharmacol. 46:680-684.
22. Tamai, I., H. Y. Ling., S. M. Timbul, J. Nishikido, and A. Tsuji. 1988. Stereospecific absorption and degradation of cephalexin. J. Pharm. Pharmacol. 40:320-324.
23. + gradient-dependent and carrier-mediated transport of cefixime, a new cephalosporin antibiotic, across brush-border membrane vesicles from rat small intestine. J. Pharmacol. Exp. Ther. 241:594-601.
24. Van Ginneken, C. A. M., and F. G. M. Russel. 1989. Saturable pharmacokinetics in the renal excretion of drugs. Clin. Pharmacokinet. 16:38-58.
25. White, D. B., C. A. Walawander, D. Y. Liu, and T. H. Grasela. 1992. Evaluation of hypothesis testing for comparing two populations using NONMEM analysis. J. Pharmacokinet. Biopharm. 20:295-313.